Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fuji
Argus Health
Moodys
Teva
Deloitte

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,629,109

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,629,109
Title:Method for promoting bone growth using activin-actriia antagonists
Abstract: In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density.
Inventor(s): Knopf; John (Carlisle, MA), Seehra; Jasbir (Lexington, MA)
Assignee: Acceleron Pharma Inc. (Cambridge, MA)
Application Number:13/176,718
Patent Claims:see list of patent claims

Details for Patent 8,629,109

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ➤ Sign Up Acceleron Pharma Inc. (Cambridge, MA) 2026-11-22 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up Acceleron Pharma Inc. (Cambridge, MA) 2026-11-22 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up Acceleron Pharma Inc. (Cambridge, MA) 2026-11-22 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Federal Trade Commission
Express Scripts
Fish and Richardson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.